WHC is still in active development. Read this to understand our approach.
depiction of JCQLEPDZFXGHHQ-UHFFFAOYSA-N.svg
tripsit

al-lad

Verificar en tripsit

psychonaut

AL-LAD

Verificar en psychonaut

isomerdesign

AL-LAD

Verificar en isomerdesign

druglab

AL-LAD

Verificar en druglab

wiki

AL-LAD

Verificar en wiki

Data

InChI: InChI=1S/C22H27N3O/c1-4-10-25-14-16(22(26)24(5-2)6-3)11-18-17-8-7-9-19-21(17)15(13-23-19)12-20(18)25/h4,7-9,11,13,16,20,23H,1,5-6,10,12,14H2,2-3H3

Sinónimos: N-Allylnorlysergic Acid N,N-Diethylamide,DTXSID30215822,N-ALLYLNORLSD,AL-LAD,(6aR,9R)-7-allyl-N,N-diethyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide,N-Allyl-nor-LSD,6-Norlysergic acid, 6-allyl-N,N-diethylamide,6-Allyl-6-nor-lysergic acid diethylamide,UNII-020O2SR91L,ERGOLINE-8-CARBOXAMIDE, 9,10-DIDEHYDRO-N,N-DIETHYL-6-(2-PROPENYL)-, (8.BETA.)-,6-allyl-6-nor-LSD,N,N-Diethylnorlysergamide, 6-allyl,N-(6)-Allylnorlysergic acid, N,N-diethylamide,65527-61-9,N,N-Diethyl-6-allyl-9,10-didehydroergoline-8beta-carboxamide,ALLAD,Q4652233,CHEMBL281787,SCHEMBL20970937,6-Norlysergamide, 6-allyl-N,N-diethyl,6-Allyl-N,N-diethyl-6-norlysergamide,020O2SR91L,9,10-Didehydro-6-allyl-N,N-diethylergoline-8β-carboxamide,allad,(6aR,9R)-N,N-diethyl-7-prop-2-enyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

Market name: al-lad

Estimated data

Solubilidad: -3.508 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 90.6% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.